Expand this Topic clickable element to expand a topic
Skip to content
Optica Publishing Group

A new resectoscope for the holmium laser resection of the prostate

Not Accessible

Your library or personal account may give you access

Abstract

The authors present a new application system for the laser resection and review their own experience in the development and clinical application of Holmium:YAG laser technology for prostatectomy. Their efforts had been to solve certain problems in the clinical application, e.g. the angle fiber/tissue in the apex area of the prostate and the movements of the shaft during the resection. Laser prostatectomy has been reported as a successful therapy for men with benign prostatic hyperplasia (BPH). Indications for the surgical treatment of BPH are refractory urinary retention, urinary tract infections, recurrent gross hematuria, bladder stones, renal insufficiency and large bladder diverticula due to BPH. Standard therapy of BPH are TURP (transurethral resection of the prostate) and open prostatectomy; these procedures are associated with a morbidity of 18% including blood loss and blood transfusion (2.9-19.6%) and transurethral resection syndrome in up to 2%. Since the mid-80's the Holmium laser has been under investigation for soft-tissue ablation, because the emitted wavelength is strongly absorbed by tissue due to its high content of water. The Holmium:YAG laser (2.140nm) has many applications in urology and can be delivered via a range of flexible low water content quartz fibers using endfiring or sidefiring techniques. The unique physical characteristics of the Holmiunv.YAG (Ho:YAG) laser makes it an effective tool to vaporize or incise tissue, including the prostate. In 1993, Gilling and Fraundorfer published a new technique of laser resection, the HoLRP. It combines the advantages of minimal perioperative morbidity, enjoyed with prior laser techniques, with the immediacy of intraoperative tissue removal and early postoperative voiding improvement. The Ho:YAG laser has been established as a new instrument for the performance of transurethral prostatectomy, which now has been demonstrated to be a safe and effective therapy for symptomatic BPH in extended clinical trials.

© 1999 Optical Society of America

PDF Article
More Like This
Preliminary Results on Diode-Laser assisted Vaporization of Prostate Tissue

Ronald Sroka, Michael Seitz, Oliver Reich, Alexander Bachmann, Verena Steinbrecher, Alexander Ackermann, and Christian Stief
6632_5 European Conference on Biomedical Optics (ECBO) 2007

Automated Handling Device for Circumferential Gigapixel Microscopy of Whole Prostate Resections

Sam Luethy and J. Quincy Brown
JW3A.3 Clinical and Translational Biophotonics (Translational) 2018

Adjuvant Photodynamic Therapy (PDT) with Photosensitizer Photosens for Superficial Bladder Cancer. Experimental investigations to treat prostate cancer by PDT with Photosens

Oleg I. Apolikhin, Igor V. Chernishov, Andrey V. Sivkov, Denis V. Altunin, Sergey G. Kuzmin, and Georgy N. Vorozhtsov
6632_64 European Conference on Biomedical Optics (ECBO) 2007

Select as filters


Select Topics Cancel
© Copyright 2024 | Optica Publishing Group. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.